These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 28661539)
1. Expression of concern: A general and concise asymmetric synthesis of sphingosine, safingol and phytosphingosines via tethered aminohydroxylation. Kelly R Org Biomol Chem; 2017 Jul; 15(27):5851. PubMed ID: 28661539 [TBL] [Abstract][Full Text] [Related]
2. Correction and removal of expression of concern: A general and concise asymmetric synthesis of sphingosine, safingol and phytosphingosines via tethered aminohydroxylation. Kumar P; Dubey A; Puranik VG Org Biomol Chem; 2020 Jul; 18(27):5265. PubMed ID: 32638807 [TBL] [Abstract][Full Text] [Related]
3. A general and concise asymmetric synthesis of sphingosine, safingol and phytosphingosines via tethered aminohydroxylation. Kumar P; Dubey A; Puranik VG Org Biomol Chem; 2010 Nov; 8(22):5074-86. PubMed ID: 20844791 [TBL] [Abstract][Full Text] [Related]
4. Expression of concern: Organocatalytic stereoselective synthesis of passifloricin A. Kelly R Org Biomol Chem; 2017 Jul; 15(27):5852. PubMed ID: 28661525 [TBL] [Abstract][Full Text] [Related]
5. Expression of concern: Enantio- and diastereocontrolled conversion of chiral epoxides to trans-cyclopropane carboxylates: application to the synthesis of cascarillic acid, grenadamide and l-(-)-CCG-II. Kelly R Org Biomol Chem; 2017 Jul; 15(27):5853. PubMed ID: 28661521 [TBL] [Abstract][Full Text] [Related]
6. Correction and removal of expression of concern: Enantio- and diastereocontrolled conversion of chiral epoxides to trans-cyclopropane carboxylates: application to the synthesis of cascarillic acid, grenadamide and l-(-)-CCG-II. Kumar P; Dubey A; Harbindu A Org Biomol Chem; 2020 Jul; 18(27):5264. PubMed ID: 32638808 [TBL] [Abstract][Full Text] [Related]
7. Retraction: Organocatalytic stereoselective synthesis of passifloricin A. Kumar P; Pandey M; Gupta P; Dhavale DD Org Biomol Chem; 2019 Feb; 17(8):2289. PubMed ID: 30735226 [TBL] [Abstract][Full Text] [Related]
8. Safingol (L-threo-sphinganine) induces autophagy in solid tumor cells through inhibition of PKC and the PI3-kinase pathway. Coward J; Ambrosini G; Musi E; Truman JP; Haimovitz-Friedman A; Allegood JC; Wang E; Merrill AH; Schwartz GK Autophagy; 2009 Feb; 5(2):184-93. PubMed ID: 19098447 [TBL] [Abstract][Full Text] [Related]
9. Efficient synthesis of D-xylo and D-ribo-phytosphingosines from methyl 2-amino-2-deoxy-beta-D-hexopyranosides. Cai Y; Ling CC; Bundle DR Carbohydr Res; 2009 Nov; 344(16):2120-6. PubMed ID: 19766990 [TBL] [Abstract][Full Text] [Related]
10. Synthesis of the dysiherbaine tetrahydropyran core utilizing improved tethered aminohydroxylation conditions. Carroll CL; Chamberlin AR Tetrahedron Lett; 2011 Aug; 52(31):3995-3997. PubMed ID: 21822338 [TBL] [Abstract][Full Text] [Related]
11. syn- and enantioselective Henry reactions of aliphatic aldehydes and application to the synthesis of safingol. Qin DD; Yu W; Zhou JD; Zhang YC; Ruan YP; Zhou ZH; Chen HB Chemistry; 2013 Dec; 19(49):16541-4. PubMed ID: 24281803 [No Abstract] [Full Text] [Related]
13. Structure-function analysis of lipid substrates and inhibitors of sphingosine kinases. Adams DR; Pyne S; Pyne NJ Cell Signal; 2020 Dec; 76():109806. PubMed ID: 33035646 [TBL] [Abstract][Full Text] [Related]
14. Sex differences in rat hepatic cytolethality of the protein kinase C inhibitor safingol: role of biotransformation. Carfagna MA; Young KM; Susick RL Toxicol Appl Pharmacol; 1996 Apr; 137(2):173-81. PubMed ID: 8661342 [TBL] [Abstract][Full Text] [Related]
15. Asymmetric synthesis of vicinal amino alcohols: xestoaminol C, sphinganine and sphingosine. Abraham E; Davies SG; Millican NL; Nicholson RL; Roberts PM; Smith AD Org Biomol Chem; 2008 May; 6(9):1655-64. PubMed ID: 18421400 [TBL] [Abstract][Full Text] [Related]
16. The role of reactive oxygen species and autophagy in safingol-induced cell death. Ling LU; Tan KB; Lin H; Chiu GN Cell Death Dis; 2011 Mar; 2(3):e129. PubMed ID: 21390063 [TBL] [Abstract][Full Text] [Related]
17. Partial inhibition of multidrug resistance by safingol is independent of modulation of P-glycoprotein substrate activities and correlated with inhibition of protein kinase C. Sachs CW; Safa AR; Harrison SD; Fine RL J Biol Chem; 1995 Nov; 270(44):26639-48. PubMed ID: 7592889 [TBL] [Abstract][Full Text] [Related]
18. A general, efficient and stereospecific route to sphingosine, sphinganines, phytosphingosines and their analogs. Cai Y; Ling CC; Bundle DR Org Biomol Chem; 2006 Mar; 4(6):1140-6. PubMed ID: 16525559 [TBL] [Abstract][Full Text] [Related]
19. Metabolism of the unnatural anticancer lipid safingol, L-threo-dihydrosphingosine, in cultured cells. Dragusin M; Gurgui C; Schwarzmann G; Hoernschemeyer J; van Echten-Deckert G J Lipid Res; 2003 Sep; 44(9):1772-9. PubMed ID: 12777464 [TBL] [Abstract][Full Text] [Related]
20. A pilot clinical/pharmacological study of the protein kinase C-specific inhibitor safingol alone and in combination with doxorubicin. Schwartz GK; Ward D; Saltz L; Casper ES; Spiess T; Mullen E; Woodworth J; Venuti R; Zervos P; Storniolo AM; Kelsen DP Clin Cancer Res; 1997 Apr; 3(4):537-43. PubMed ID: 9815717 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]